Date
| Speaker
| Department
| Title
|
| 2/2/22 | Dr. Thomas Scherer | Medical University of Vienna, Austria | Leptin-A regulator of hepatic lipid mechanism |
| 3/2/22 | Dr. Jennifer Stancill | Medical College of Wisconsin | Protective Mechanisms Pancreatic β-cells: From Antioxidants to Antivirals |
| 3/9/22 | Dr. Kathleen Corey | Harvard Medical School | Non-Alcoholic Fatty Liver Disease as a Risk Factor for Cardiovascular Disease |
| 3/16/22 | Dr. Lisandra de Castro Bras | East Carolina University | Using Natural Peptides To Prevent Long-term Adverse Cardiac Remodeling |
| 4/27/22 | Dr. Renata Pereria | University of Iowa | ATF4 Integrates Mitochondrial Stress in Brown Adipose Tissue with Improved Metabolic Fitness |
| 5/4/22 | Dr. Sonia Najjar | Ohio University | Is Non-alcoholic Steatohepatitis an Insulin Resistance Disease? |
| 5/11/22 | Dr. Marat Fudim | Duke University | NAFLD and Heart Failure |
| 5/25/22 | Dr. Harini Sampath | Rutgers University | Regulation of Metabolic Health by Intestinal Delta-9 Desaturases |
| 6/22/22 | Dr. Robert Raffai | University of California-San Francisco Parnassus | Macrophage Exosomes as mediators and therapeutics for cardiometabolic inflammation |
| 7/20/22 | Dr. Keisa Mathis | University of North Texas Health Science Center | Understanding the pathogenesis of lupus hypertension and renal injury |
| 8/10/22 | Dr. Pooja Shukla | University of Missouri | A simple, non-invasive model to characterize pulmonary oxygen transport |
| 9/14/22 | Dr. Bryan Becker | University of Alabama, Birmingham | An update on renal nerves, salt and blood pressure control |
| 10/5/22 | Dr. Osvaldo Rivera-Gonzalez | National Institutes of Diabetes and Digestive and Kidney Diseases | Investigating GI-signaling in enteroendocrine K-Cells |
| Dr. Kyle Moore | University of Alabama at Brimingham | Resident memory-like T cells in an aristolochic acid-induced model of CKD |
| 10/19/22 | Dr. Tristan Clemons | University of Southern Mississippi | Bio-inspired supramolecular polymers for regenerative medicine applications |
| 12/14/22 | Dr. Arion Kennedy | North Carolina State University | The role of MHC class I in nonalchologic fatty liver disease |